Skip to main content
Fig. 6 | Annals of Clinical Microbiology and Antimicrobials

Fig. 6

From: A novel antibiotic combination of linezolid and polymyxin B octapeptide PBOP against clinical Pseudomonas aeruginosa strains

Fig. 6

Residual CFUs and survival rate of C. elegans infected with P. aeruginosa. The C. elegans were infected at day 0 with PA14 and treated with PBS, linezolid, PBOP or LP for determining bacterial burdens at post treatment 12 h (A) and 24 h (B). The survival rate of C. elegans was monitored for the subsequent 7 days (C). PBS was used as a control. **p < 0.01 and ***p < 0.001

Back to article page